Insider Transactions in Q3 2024 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
David O. Watson General Counsel |
BUY
Bona fide gift
|
Direct |
10,569
+8.24%
|
-
|
|
Sep 27
2024
|
David O. Watson General Counsel |
SELL
Bona fide gift
|
Indirect |
10,569
-13.1%
|
-
|
|
Sep 23
2024
|
A. Sinclair Dunlop Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+2.94%
|
$59,800
$13.19 P/Share
|
|
Sep 16
2024
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Indirect |
37,000
-14.26%
|
$1,332,000
$36.44 P/Share
|
|
Sep 16
2024
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
192
-0.5%
|
$6,912
$36.21 P/Share
|
|
Sep 03
2024
|
James George Chopas VP/Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
550
-1.41%
|
$21,450
$39.49 P/Share
|
|
Aug 12
2024
|
Mark Jeffrey De Long Chief Business & Strat Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,201
+7.93%
|
$67,613
$13.85 P/Share
|